ARTH
Price
$0.18
Change
-$0.05 (-21.74%)
Updated
Mar 7 closing price
Capitalization
804.43K
BIVI
Price
$1.09
Change
-$0.10 (-8.40%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
21.96M
Ad is loading...

ARTH vs BIVI

Header iconARTH vs BIVI Comparison
Open Charts ARTH vs BIVIBanner chart's image
Arch Therapeutics
Price$0.18
Change-$0.05 (-21.74%)
Volume$770
Capitalization804.43K
BioVie
Price$1.09
Change-$0.10 (-8.40%)
Volume$792
Capitalization21.96M
ARTH vs BIVI Comparison Chart
Loading...
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARTH vs. BIVI commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTH is a Hold and BIVI is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ARTH: $0.18 vs. BIVI: $1.19)
Brand notoriety: ARTH and BIVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTH: 22% vs. BIVI: 26%
Market capitalization -- ARTH: $804.43K vs. BIVI: $21.96M
ARTH [@Biotechnology] is valued at $804.43K. BIVI’s [@Biotechnology] market capitalization is $21.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTH’s FA Score shows that 0 FA rating(s) are green whileBIVI’s FA Score has 1 green FA rating(s).

  • ARTH’s FA Score: 0 green, 5 red.
  • BIVI’s FA Score: 1 green, 4 red.
According to our system of comparison, BIVI is a better buy in the long-term than ARTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIVI’s TA Score shows that 4 TA indicator(s) are bullish.

  • BIVI’s TA Score: 4 bullish, 4 bearish.

Price Growth

ARTH (@Biotechnology) experienced а -22.13% price change this week, while BIVI (@Biotechnology) price change was -10.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

ARTH is expected to report earnings on Aug 30, 2023.

BIVI is expected to report earnings on Nov 27, 2024.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIVI($22M) has a higher market cap than ARTH($804K). ARTH YTD gains are higher at: 6.471 vs. BIVI (-40.500). ARTH has higher annual earnings (EBITDA): -8.68M vs. BIVI (-23.19M). BIVI has more cash in the bank: 20M vs. ARTH (30K). BIVI has less debt than ARTH: BIVI (3.72M) vs ARTH (9.39M). ARTH has higher revenues than BIVI: ARTH (148K) vs BIVI (0).
ARTHBIVIARTH / BIVI
Capitalization804K22M4%
EBITDA-8.68M-23.19M37%
Gain YTD6.471-40.500-16%
P/E RatioN/AN/A-
Revenue148K0-
Total Cash30K20M0%
Total Debt9.39M3.72M253%
FUNDAMENTALS RATINGS
ARTH vs BIVI: Fundamental Ratings
ARTH
BIVI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
8797
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIVI's Valuation (21) in the null industry is significantly better than the same rating for ARTH (87). This means that BIVI’s stock grew significantly faster than ARTH’s over the last 12 months.

BIVI's Profit vs Risk Rating (100) in the null industry is in the same range as ARTH (100). This means that BIVI’s stock grew similarly to ARTH’s over the last 12 months.

BIVI's SMR Rating (99) in the null industry is in the same range as ARTH (100). This means that BIVI’s stock grew similarly to ARTH’s over the last 12 months.

ARTH's Price Growth Rating (87) in the null industry is in the same range as BIVI (97). This means that ARTH’s stock grew similarly to BIVI’s over the last 12 months.

ARTH's P/E Growth Rating (100) in the null industry is in the same range as BIVI (100). This means that ARTH’s stock grew similarly to BIVI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIVI
RSI
ODDS (%)
Bullish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CXXRX22.290.13
+0.59%
Columbia Small Cap Index Inst2
VTCIX147.280.71
+0.48%
Vanguard Tax-Managed Capital App I
PURGX19.660.06
+0.31%
PGIM Global Real Estate R4
RMORX22.25N/A
N/A
Victory RS Mid Cap Growth R6
GSBEX14.44-0.05
-0.35%
Goldman Sachs Small Cap Growth R6

ARTH and

Correlation & Price change

A.I.dvisor tells us that ARTH and EDSA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARTH and EDSA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTH
1D Price
Change %
ARTH100%
-22.13%
EDSA - ARTH
21%
Poorly correlated
+0.43%
HRMY - ARTH
20%
Poorly correlated
-0.12%
BIVI - ARTH
13%
Poorly correlated
-0.83%
APLIF - ARTH
12%
Poorly correlated
+18.48%
BETRF - ARTH
5%
Poorly correlated
N/A
More

BIVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIVI has been loosely correlated with HOFBF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BIVI jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIVI
1D Price
Change %
BIVI100%
-0.83%
HOFBF - BIVI
44%
Loosely correlated
N/A
HURA - BIVI
42%
Loosely correlated
+2.45%
SCNI - BIVI
34%
Loosely correlated
+1.59%
BIORQ - BIVI
33%
Loosely correlated
-6.83%
VANI - BIVI
31%
Poorly correlated
-0.92%
More